The interplay between heart rate variability, inflammation, and lipid accumulation: Implications for cardiometabolic risk
Physiological Reports · 2025
DOI: 10.14814/phy2.70313 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2025. Verfasst von Cameron R Wiley und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological Science, University of California, Irvine, Irvine, California, USA. Hauptthemen laut MEDLINE: Heart Rate, Inflammation, Cardiovascular Diseases, Lipid Accumulation Product. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mannheimer Institute für Public Health, Sozial- und Präventivmedizin.
Abstract (Originalsprache)
Deleterious adiposity (e.g., obesity) is considered an inflammatory condition that increases risk for cardiovascular diseases. Lower heart rate variability (HRV), an independent predictor of cardiovascular disease risk, is linked with higher levels of adiposity and inflammation. However, indices of adiposity vary in their strength of association with disease risk. Body mass index (BMI) is a modest predictor of disease, while the lipid accumulation product (LAP) better predicts disease risk. The current investigation used cross‐sectional and prospective designs to probe the differential associations between HRV and multiple measures of adiposity (e.g., LAP and BMI) and examine if inflammation (measured via C‐reactive protein; CRP) mediated these associations. Study 1 showed that HRV was more strongly linked with LAP relative to other adiposity measures and that this link was mediated by CRP. Study 2 replicated Study 1 results and showed that this association remained significant 4 years later. Our novel findings are consistent with studies suggesting LAP may be a superior measure of cardiovascular disease risk relative to other measures of adiposity. Importantly, the strong link between HRV and LAP was mediated by inflammation, highlighting the key role of the cholinergic anti‐inflammatory pathway in regulating obesity and associated health consequences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychological Science, University of California, Irvine, Irvine, California, USA.
- Institute of Medical Psychology, Center for Psychosocial Medicine, University Hospital Heidelberg, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.
- Department of Psychosomatic Medicine and Psychotherapy, Ulm University Medical Center, Ulm, Germany.
- Mannheim Institute of Public Health, Social and Preventive Medicine, Mannheim Medical Faculty, Heidelberg University, Mannheim, Germany.
- BIOTEKNA Biomedical Technologies, Venice, Italy.
- Open Academy of Medicine, London, UK.
ORCID-Profile: Cameron R Wiley, Julian F Thayer, DeWayne P Williams
Förderung
- Mannheimer Institute für Public Health, Sozial- und Präventivmedizin
Zitieren
APA
Wiley, C. R., Pourmand, V., Stevens, S. K., Jarczok, M. N., Fischer, J. E., Boschiero, D., Poggiogalle, E., Koenig, J., Thayer, J. F., & Williams, D. P. (2025). The interplay between heart rate variability, inflammation, and lipid accumulation: Implications for cardiometabolic risk. Physiological Reports. https://doi.org/10.14814/phy2.70313
Vancouver
Wiley CR, Pourmand V, Stevens SK, Jarczok MN, Fischer JE, Boschiero D, et al. The interplay between heart rate variability, inflammation, and lipid accumulation: Implications for cardiometabolic risk. Physiological Reports. 2025. doi:10.14814/phy2.70313
BibTeX
@article{Wiley2025,
author = {Wiley, Cameron R and Pourmand, Vida and Stevens, Sarah K and Jarczok, Marc N and Fischer, Joachim E and Boschiero, Dario and Poggiogalle, Eleonora and Koenig, Julian and Thayer, Julian F and Williams, DeWayne P},
title = {The interplay between heart rate variability, inflammation, and lipid accumulation: Implications for cardiometabolic risk},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70313}
}
EUVIMED